Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2016

Oct 24, 2016

30071_dirs_2016-10-24_136d8284-0b81-4a8f-a3e9-cbf228970119.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-10-19

Reporting Person: ROBERTS CHRISTOPHER G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-10-19 ResMed Common Stock M 36000 $25.54 Acquired 145610 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-10-19 ResMed Common Stock Options $25.54 A 36000 Acquired 2016-12-17 ResMed Common Stock (36000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 323900 Indirect
ResMed Common Stock 136000 Indirect
ResMed Common Stock 23200 Indirect

Footnotes

F1: Exercise options and hold shares acquired through purchase.

F2: Options vest in full (a) on the first Nov. 11 following the grant date or (b) the first annual shareholder's meeting following grant date.